8 Tipping Points: Pharm Exec s 2019 Industry Forecast

Welcome once again to Pharm Exec s annual look at what s ahead for the biopharma industry, where we hope the eight trends singled out for this year capture the pulse of change and opportunity impacting leaders and decision-makers in the life sciences the most. From technology and digital hea Powered by WPeMatico Continue reading 8 Tipping Points: Pharm Exec s 2019 Industry Forecast

Future Pharma: Data Science as a Strategic Partner

Leaders at Novartis share how the big pharma is laying the foundations for a potential new operating model as a “medicines and data science company” At the beginning of 2018, Novartis CEO Vas Narasimhan spoke of reimagining Novartis as a medicines and data science com Powered by WPeMatico Continue reading Future Pharma: Data Science as a Strategic Partner

Securing a Winning Strategy for Real-World Evidence

While the increasing importance of real-world evidence (RWE) is widely acknowledged, the dramatic shift required by biopharma companies to embed and secure an RWE capability effectively across the organization is still a work in progress In Deloitte s Second Annual Real-World Powered by WPeMatico Continue reading Securing a Winning Strategy for Real-World Evidence

Identity Crisis: Data Protection Roles for Life Sciences Companies

James Clark The advent of the General Data Protection Regulation (GDPR) has brought with it a complicated range of challenges for businesses operating in life sciences. From transparency and privacy notices, to the use of consent, from contracts with service providers, to extended data Powered by WPeMatico Continue reading Identity Crisis: Data Protection Roles for Life Sciences Companies

5 Ways to Shape a Regulatory Affairs Workforce for the Future

Karin Van Baelen With the ever-changing healthcare landscape, I encourage my Global Regulatory Affairs (GRA) team at Janssen R&D to be nimble, curious and forward-thinking in everything they do. Why? Because with more than 30 years spent in pharmaceutical R&D and regulatory, I a Powered by WPeMatico Continue reading 5 Ways to Shape a Regulatory Affairs Workforce for the Future

Experts Probe Economic Factors Driving Drug Shortages

Patients, providers and policy makers are up in arms over persistent and more prevalent shortages of important medicines, primarily generic sterile injectables needed to treat critical diseases and infections, provide emergency care, and enable surgery and multiple aspects of medical care. Despi Powered by WPeMatico Continue reading Experts Probe Economic Factors Driving Drug Shortages